Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Epigenomic Mapping Highlights Differences Between Ancient and Modern Humans

By BiotechDaily International staff writers
Posted on 05 May 2014
Image: Working in a clean room, researchers at the Max Planck Institute for Evolutionary Anthropology took extensive precautions to avoid contaminating Neanderthal DNA samples - extracted from bones like this one - with DNA from any other source, including modern humans (Photo courtesy of the Max Planck Institute for Evolutionary Anthropology).
Image: Working in a clean room, researchers at the Max Planck Institute for Evolutionary Anthropology took extensive precautions to avoid contaminating Neanderthal DNA samples - extracted from bones like this one - with DNA from any other source, including modern humans (Photo courtesy of the Max Planck Institute for Evolutionary Anthropology).
Molecular biologists employing advanced epigenetic techniques have identified genetic differences between Homo sapiens and extinct types of humans such as Neanderthals and Denisovans that are linked to modern diseases like Alzheimer’s disease, autism, and schizophrenia.

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell. Epigenetic modifications are reversible modifications to a cell’s DNA or histones that affect gene expression without altering the DNA sequence. Two of the most characterized epigenetic modifications are DNA methylation and histone modification. Epigenetic modifications play an important role in gene expression and regulation, and are involved in numerous cellular processes such as in differentiation/development and tumorigenesis. Recent advances in high-throughput analytical technology have enabled rapid advances in epigenomic research.

The evolution of epigenetic regulation along the human lineage remains largely unexplored. To shed further light on this topic, investigators at the Hebrew University of Jerusalem (Israel) and their colleagues at the Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany) reconstructed the full DNA methylation maps of the Neandertal and the Denisovan by harnessing the natural degradation processes of methylated and unmethylated cytosines.

The investigators reported in the April 17, 2014, online edition of the journal Science that by comparing these ancient methylation maps to those of present-day humans, they had identified nearly 2000 differentially methylated regions (DMRs). Particularly, they found substantial methylation changes in the HOXD cluster that may explain anatomical differences between archaic and present-day humans. Hox genes (from an abbreviation of homeobox) are a group of related genes that control the body plan of the embryo along the anterior-posterior axis. After the embryonic segments have formed, the Hox proteins determine the type of segment structures (e.g., legs, antennae, and wings in fruit flies or the different types of vertebrae in humans) that will form on a given segment.

Additionally, the investigators found that DMRs were significantly more likely to be associated with modern diseases such as Alzheimer’s disease, autism and schizophrenia, suggesting that recent epigenetic changes in brain tissues may underlie some of today's common psychiatric disorders.

The authors concluded by saying, "This study provides insight into the epigenetic landscape of our closest evolutionary relatives and opens a window to explore the epigenomes of extinct species."

Related Links:

Hebrew University of Jerusalem
Max Planck Institute for Evolutionary Anthropology



Channels

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.